top of page
600x400-scripps-with-spectrum-on-black_e

Past Highlighted Publications v2

How Blocking a Neural Receptor Responsible for Addiction Could Reduce Alcohol Use

How Blocking a Neural Receptor Responsible for Addiction Could Reduce Alcohol Use

A Scripps Research team found that a new therapeutic that targets the kappa opioid receptor in the brain may reduce alcohol dependence.

How Mifepristone Could Transform Treatments for Alcohol Addiction

How Mifepristone Could Transform Treatments for Alcohol Addiction

This study investigates whether mifepristone, a glucocorticoid receptor antagonist, can reduce innate anxiety-like behaviors in genetically-selected Marchigian Sardinian (msP) rats.

New Hope for Battling Alcoholism: Glucocorticoid Blockers Show Promise

New Hope for Battling Alcoholism: Glucocorticoid Blockers Show Promise

Researchers explore how blocking specific stress-related receptors can reduce alcohol consumption in both everyday and genetically predisposed rats, paving the way for potential new treatments for alcohol use disorder.

How Blocking a Neural Receptor Responsible for Addiction Could Reduce Alcohol Use

How Blocking a Neural Receptor Responsible for Addiction Could Reduce Alcohol Use

A Scripps Research team found that a new therapeutic that targets the kappa opioid receptor in the brain may reduce alcohol dependence.

How Mifepristone Could Transform Treatments for Alcohol Addiction

How Mifepristone Could Transform Treatments for Alcohol Addiction

This study investigates whether mifepristone, a glucocorticoid receptor antagonist, can reduce innate anxiety-like behaviors in genetically-selected Marchigian Sardinian (msP) rats.

AA006420 Alcohol Center Grant

bottom of page